Process for FDA Data Requests To Inform Certain Over-the-Counter Monograph Drug Activities; Procedure
The Food and Drug Administration (FDA or Agency) is announcing the process for FDA to issue Data Requests for the submission of data from the public to help inform certain future over-the counter (OTC) monograph drug activities, including development of FDA-initiated proposed orders to modify conditions described in an OTC monograph. FDA is issuing this notice to inform the public and interested parties of the process that FDA is implementing to issue these Data Requests.
Read the official notice →Source: Federal Register (FDA/USDA food labeling) · US Government work (public domain). This is a short, attributed summary; the full authoritative text lives on the authority’s own site. LabelYog does not author or endorse it — confirm compliance against the destination market’s official source.
More from United States
- Notice of Request To Renew an Approved Information Collection: Salmonella Initiative Program regulatory
- Reforming and Modernizing the NRC's Radiation Protection Framework regulatory
- Self-Regulatory Organizations; Cboe Exchange, Inc.; Notice of Filing of a Proposed Rule Change To Amend its Rules To Permit the Listing of Binary Options Overlying Key Performance Indicators (“KPIs”) Reported by Certain Issuers of Stock (“Binary KPI Options”) regulatory
- Formal Meetings Between FDA and Sponsors or Requestors of Over-the-Counter Monograph Drugs regulatory
- Bacteriophage Active Against Xanthomonas campestris pv. vesicatoria_EcoPhage and Bacteriophage Active Against Pseudomonas syringae pv. tomato_EcoPhage; Exemptions from the Requirement of a Pesticide Tolerance regulatory
- Amendments and Nonconformance Penalties for Model Year 2027 and Later Heavy-Duty Highway Engines and Amendments to Inducement Provisions for SCR-Equipped Diesel Engines regulatory
What this means for your label
A notice like this changes what a pack must carry. These are the rules we build against, starting with US FDA.